EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Developmental Patterns of Hepatic Peroxisome Proliferator‐Activated Receptor (PPAR) Expression in Xenopus laevis and Response to Pharmaceutical Agonists During Metamorphic Climax

Anna Bushong, Tyler D Hoskins, Meredith Scherer, Maria S Sepúlveda iD

Journal of Experimental Zoology Part A: Ecological and Integrative Physiology · 2025

DOI: 10.1002/jez.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, 2025. Verfasst von Anna Bushong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Odum School of Ecology, University of Georgia, Athens, Georgia, USA. Hauptthemen laut MEDLINE: Xenopus laevis, Peroxisome Proliferator-Activated Receptors, Metamorphosis, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was partially funded by a Strategic Environmental Research and Development Program (SERDP) Grant (ER-2626) awarded to MSS and by the U.S. Department….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peroxisome proliferator‐activated receptors (PPAR) are master transcriptional regulators that maintain metabolic homeostasis in vertebrates. Amphibians are often exposed to endocrine disrupting compounds (EDCs) that could dysregulate lipid metabolism. Larvae of the African clawed frog ( Xenopus laevis ) are routinely used as a model to study aquatic EDC exposures, but PPAR expression has not been characterized across larval development or metamorphosis in this species. We conducted two experiments to elucidate (a) the expression in late metamorphosis for xPPAR α / β / γ subtypes, and (b) the effect of pharmaceutical PPAR agonists (pirinixic acid, bezafibrate, and ciprofibrate) on the expression of xPPAR α / β / γ target genes. Additionally, we considered apical endpoints (body mass, body condition [scaled mass index, SMI], and relative liver mass). We hypothesized pharmaceuticals would agonize hepatic xPPAR α / β / γ , upregulating expression of downstream target genes and reducing apical endpoints with variation reflective of developmental patterns of nuclear receptor expression. We observed upregulation of xPPAR α during late premetamorphosis (NF 51), prometamorphosis (NF 56–57), and metamorphic climax (NF 58–66), which also held for xPPAR γ with exception for peak of metamorphic climax (NF 62). For xPPAR β , we only observed upregulation at conclusion of metamorphic climax (NF 66). Agonists did not cause changes in gene expression for xPPAR α / β / γ targets, but pirinixic acid exposure decreased female body condition. The dynamic hepatic expression of xPPAR α / β / γ during late metamorphosis is presumably necessary to coordinate energy flux and highlights a potential period of susceptibility to PPAR agonism. However, pharmaceuticals identified to interact with xPPARα/β/γ did not elicit a response concordant with PPAR agonism at high doses. These results suggest that X. laevis may not be a sensitive model for studies testing PPAR‐mediated effects of xenobiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xenopus laevisPeroxisome Proliferator-Activated ReceptorsMetamorphosis, BiologicalAnimalsLiverLarvaGene Expression Regulation, DevelopmentalPyrimidinesBezafibrateFibric AcidsMaleFemale

Stichwörter der Autor:innen

PPARWY‐14643amphibianbezafibrateciprofibrateecotoxicology

Substanzen

Peroxisome Proliferator-Activated Receptorspirinixic acidPyrimidinesBezafibrateciprofibrateFibric Acids

Autor:innen und Institutionen

  • Odum School of Ecology, University of Georgia, Athens, Georgia, USA.
  • Savannah River Ecology Laboratory, University of Georgia, Aiken, South Carolina, USA.
  • Department of Forestry and Natural Resources, Purdue University, West Lafayette, Indiana, USA.
  • Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.

ORCID-Profile: Maria S Sepúlveda

Förderung

  • This study was partially funded by a Strategic Environmental Research and Development Program (SERDP) Grant (ER-2626) awarded to MSS and by the U.S. Department…

Zitieren

APA

Bushong, A., Hoskins, T. D., Scherer, M., & Sepúlveda, M. S. (2025). Developmental Patterns of Hepatic Peroxisome Proliferator‐Activated Receptor (PPAR) Expression in Xenopus laevis and Response to Pharmaceutical Agonists During Metamorphic Climax. Journal of Experimental Zoology Part A: Ecological and Integrative Physiology. https://doi.org/10.1002/jez.70031

Vancouver

Bushong A, Hoskins TD, Scherer M, Sepúlveda MS. Developmental Patterns of Hepatic Peroxisome Proliferator‐Activated Receptor (PPAR) Expression in Xenopus laevis and Response to Pharmaceutical Agonists During Metamorphic Climax. Journal of Experimental Zoology Part A: Ecological and Integrative Physiology. 2025. doi:10.1002/jez.70031

BibTeX
@article{Bushong2025,
  author = {Bushong, Anna and Hoskins, Tyler D and Scherer, Meredith and Sepúlveda, Maria S},
  title = {Developmental Patterns of Hepatic Peroxisome Proliferator‐Activated Receptor (PPAR) Expression in Xenopus laevis and Response to Pharmaceutical Agonists During Metamorphic Climax},
  journal = {Journal of Experimental Zoology Part A: Ecological and Integrative Physiology},
  year = {2025},
  doi = {10.1002/jez.70031}
}
Kostenlos starten →